Healthcare giant CVS Health boosted its outlook for the year as part of its investor day on Tuesday. The company said it now expects full-year revenues of at least $400 billion and earnings per share ...

As narrative CVs become more widely adopted by funders and institutions, researchers are being asked to rethink how they present their careers. Unlike traditional CVs, which rely heavily on lists of ...

For many, the main point of investing is to generate higher returns than the overall market. But even the best stock picker will only win with some selections. So we wouldn't blame long term CVS ...

CVS Health Corporation (NYSE:CVS) shareholders should be happy to see the share price up 23% in the last month. But that cannot eclipse the less-than-impressive returns over the last three years.

Despite recent struggles, I remain bullish on CVS due to its potential for long-term growth and undervaluation, with a strong support level around $50. CVS faces challenges like high debt levels and ...

Big is bad, in the view of many, and bigger is badder. In the context of many proposed business mergers, that stance makes far less sense than commonly assumed, and it is likely to lead to adverse ...

While the demand for low-wage and hourly-wage work is rising in the United States, the number of people available to fill those jobs is shrinking substantially. But one company -- CVS/Pharmacy -- has ...